Alexandria, VA – July 13, 2023 – The Innovation and Value Initiative (IVI), a non-profit research organization committed to advancing the science, practice, and use of health technology assessment (HTA) in healthcare, today announced the release of its 2022 Annual Report.
The 2022 Annual Report highlights IVI’s key milestones and significant accomplishments across all aspects of the organization. IVI maintained a strong financial performance in 2022, which enabled them to increase investments in research, convenings, operations, and outreach. In addition to adding five new staff members, IVI also launched three innovative programs:
- Economic Impact Project: This project offers guidance on how to incorporate the full range of economic impacts on patients and caregivers into comparative effectiveness research and patient-centered health technology assessment (HTA).
- Health Equity Initiative: This initiative seeks to embed health equity throughout our research projects, educational offerings, and patient and stakeholder engagement activities to catalyze action in the development of methods in HTA that promote equity in health access and outcomes.
- Valuing Innovation Project: A multi-phase initiative, this project will help advance the dialogue, identify gaps in current HTA approaches, and build consensus on practical methods to better measure and reward innovation.
“I am incredibly excited for the future of IVI,” says Jason Spangler, IVI’s Chief Executive Officer. “We have an exceptionally talented team at IVI that is focused on decisive action to transform health technology assessment—in practice and policy—through our sustained action, innovation, and collaboration.”
Looking to the future, IVI plans to explore new approaches in HTA that advance the understanding of patient-centered outcomes in rare disease, release their Major Depressive Disorder Open-Source Value Model, develop a framework on how stakeholders can incorporate economic impacts into HTA, host their 4th Annual Methods Summit, and ensure that equity, patient-centricity, transparency, and value are at the forefront of all Inflation Reduction Act conversations.
Read the full annual report here.
The Innovation and Value Initiative (IVI) is a 501(c)(3) tax-exempt, non-profit research organization dedicated to advancing the science and improving the practice of health technology assessment through development of novel methods and the creation and application of enhanced health technology assessment models to support local decision-making needs in healthcare.
Contact: Smita Sanwardeker
E-Mail: [email protected]